Maryam Hassanpour, DO
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Indian Health Center of Santa Clara Valley · 37 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hassanpour’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$262,593 in 2024
Medicaid paid $262,593 for 3,416 billed services this clinician did in 2024, up to 147 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,167 | $260,290 |
| Short return visit | 2,030 | $2,030 |
| Short return visit (20+ min) | 157 | $248 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 38 | $25 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 24 | $0 |
| 2024 | 3,416 | 5 | 147 | $262,593 |
| 2023 | 3,673 | 3 | 168 | $276,855 |
| 2022 | 2,466 | 4 | 114 | $182,063 |
| 2021 | 3,780 | 7 | 174 | $300,928 |
| 2020 | 3,052 | 8 | 136 | $259,035 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,282 | $275,631 |
| Short return visit | 2,352 | $1,181 |
| Short return visit (20+ min) | 39 | $43 |
2022
| Clinic visit/encounter, all-inclusive | 889 | $181,781 |
| Short return visit (20+ min) | 925 | $128 |
| Short return visit | 479 | $90 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 173 | $64 |
2021
| Clinic visit/encounter, all-inclusive | 1,465 | $300,750 |
| Short return visit | 844 | $127 |
| Short return visit (20+ min) | 1,180 | $50 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 22 | $0 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 118 | $0 |
| New patient visit (30+ min) | 81 | $0 |
| Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 70 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,270 | $258,790 |
| Short return visit (20+ min) | 1,100 | $214 |
| Short return visit | 234 | $31 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 21 | $0 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 106 | $0 |
| New patient visit (30+ min) | 38 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 237 | $0 |
| Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 46 | $0 |
Drugs they prescribed that Part D paid
$101,918
Pharmacies billed $101,918 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (16 of 1,379) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,204 generic and fewer than 11 brand-name prescriptions · $101,918 in drug cost · 26 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 33 | $28,887 | $875 |
| Januvia | 11 | $12,413 | $1,128 |
| Ozempic | 14 | $10,729 | $766 |
| Atorvastatin | 133 | $903 | $7 |
| Albuterol Sulfate Hfa | 24 | $743 | $31 |
See all 34 drugs
| Jardiance | 33 | $28,887 | $875 |
| Januvia | 11 | $12,413 | $1,128 |
| Ozempic | 14 | $10,729 | $766 |
| Atorvastatin | 133 | $903 | $7 |
| Albuterol Sulfate Hfa | 24 | $743 | $31 |
| Amlodipine Besylate | 77 | $477 | $6 |
| Metformin | 78 | $466 | $6 |
| Gabapentin | 37 | $449 | $12 |
| Omeprazole | 51 | $372 | $7 |
| Mirtazapine | 11 | $365 | $33 |
| Levothyroxine | 51 | $283 | $6 |
| Losartan | 35 | $233 | $7 |
| Duloxetine | 14 | $225 | $16 |
| Tamsulosin | 23 | $196 | $9 |
| Pravastatin | 19 | $195 | $10 |
| Lisinopril | 41 | $181 | $4 |
| Pantoprazole | 27 | $173 | $6 |
| Trazodone | 26 | $165 | $6 |
| Nitrofurantoin Mono-Macro | 11 | $135 | $12 |
| Rosuvastatin | 15 | $133 | $9 |
| Metoprolol | 12 | $130 | $11 |
| Metoprolol | 27 | $119 | $4 |
| Ibuprofen | 23 | $114 | $5 |
| Fluticasone Propionate | 14 | $109 | $8 |
| Simvastatin | 27 | $105 | $4 |
| Famotidine | 17 | $93 | $5 |
| Glipizide | 17 | $85 | $5 |
| Sumatriptan | 13 | $71 | $5 |
| Meclizine | 13 | $59 | $5 |
| Naproxen | 11 | $56 | $5 |
| Alendronate | 15 | $56 | $4 |
| Atenolol | 11 | $54 | $5 |
| Promethazine | 15 | $41 | $3 |
| Hydrochlorothiazide | 17 | $38 | $2 |
Year by year
| 2024 | 1,379 | 248 | 1% (16) | None | $101,918 |
| 2023 | 1,377 | 284 | None | None | $103,847 |
| 2022 | 1,291 | 174 | 1% (18) | None | $56,127 |
| 2021 | 905 | 111 | None | 10% | $54,929 |
| 2020 | 389 | 65 | 3% (12) | None | $20,291 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Januvia | 16 | $15,962 | $998 |
| Ozempic | 11 | $10,561 | $960 |
| Atorvastatin | 111 | $2,282 | $21 |
| Losartan | 48 | $1,638 | $34 |
| Amlodipine Besylate | 87 | $1,330 | $15 |
| Metformin | 80 | $1,187 | $15 |
| Levothyroxine | 44 | $1,015 | $23 |
| Diclofenac | 22 | $914 | $42 |
| Albuterol Sulfate Hfa | 22 | $849 | $39 |
| Pravastatin | 25 | $716 | $29 |
| Tamsulosin | 21 | $635 | $30 |
| Metoprolol | 16 | $582 | $36 |
| Omeprazole | 49 | $563 | $11 |
| Lisinopril | 46 | $552 | $12 |
| Alendronate | 18 | $522 | $29 |
| Gabapentin | 25 | $509 | $20 |
| Donepezil | 15 | $490 | $33 |
| Famotidine | 27 | $471 | $17 |
| Pantoprazole | 23 | $393 | $17 |
| Trazodone | 31 | $366 | $12 |
| Rosuvastatin | 17 | $330 | $19 |
| Clonazepam | 23 | $321 | $14 |
| Simvastatin | 18 | $314 | $17 |
| Fluticasone Propionate | 24 | $252 | $11 |
| Ibuprofen | 22 | $234 | $11 |
| Lorazepam | 13 | $205 | $16 |
| Metoprolol | 21 | $186 | $9 |
| Zolpidem | 13 | $139 | $11 |
| Hydrochlorothiazide | 21 | $103 | $5 |
2022: 24 drugs
| Combivent Respimat | 11 | $5,542 | $504 |
| Atorvastatin | 113 | $1,527 | $14 |
| Gabapentin | 56 | $1,084 | $19 |
| Losartan | 48 | $1,035 | $22 |
| Levothyroxine | 49 | $964 | $20 |
| Pravastatin | 34 | $705 | $21 |
| Metformin | 71 | $653 | $9 |
| Metoprolol | 19 | $632 | $33 |
| Omeprazole | 49 | $605 | $12 |
| Amlodipine Besylate | 67 | $599 | $9 |
| Alendronate | 36 | $576 | $16 |
| Diclofenac | 11 | $435 | $40 |
| Rosuvastatin | 17 | $418 | $25 |
| Fluticasone Propionate | 25 | $350 | $14 |
| Lisinopril | 39 | $304 | $8 |
| Ibuprofen | 20 | $251 | $13 |
| Famotidine | 20 | $239 | $12 |
| Furosemide | 45 | $197 | $4 |
| Pantoprazole | 12 | $197 | $16 |
| Trazodone | 18 | $171 | $10 |
| Amitriptyline | 11 | $143 | $13 |
| Hydrochlorothiazide | 17 | $74 | $4 |
| Metoprolol | 12 | $54 | $4 |
| Lisinopril-Hydrochlorothiazide | 14 | $50 | $4 |
2021: 20 drugs
| Atorvastatin | 80 | $1,242 | $16 |
| Gabapentin | 43 | $757 | $18 |
| Levothyroxine | 31 | $701 | $23 |
| Pravastatin | 31 | $521 | $17 |
| Ibuprofen | 39 | $486 | $12 |
| Omeprazole | 34 | $434 | $13 |
| Ezetimibe | 12 | $413 | $34 |
| Metformin | 46 | $364 | $8 |
| Amlodipine Besylate | 44 | $349 | $8 |
| Propranolol | 11 | $344 | $31 |
| Lisinopril | 28 | $288 | $10 |
| Alendronate | 28 | $280 | $10 |
| Sertraline | 19 | $214 | $11 |
| Fluticasone Propionate | 15 | $188 | $13 |
| Trazodone | 14 | $172 | $12 |
| Nortriptyline | 11 | $150 | $14 |
| Famotidine | 11 | $120 | $11 |
| Allopurinol | 11 | $58 | $5 |
| Hydrochlorothiazide | 13 | $47 | $4 |
| Furosemide | 18 | $38 | $2 |
2020: 10 drugs
| Albuterol Sulfate Hfa | 11 | $508 | $46 |
| Atorvastatin | 22 | $234 | $11 |
| Ibuprofen | 21 | $184 | $9 |
| Hydrocodone-Acetaminophen | 11 | $172 | $16 |
| Lisinopril | 20 | $165 | $8 |
| Fluticasone Propionate | 11 | $153 | $14 |
| Metformin | 17 | $95 | $6 |
| Amlodipine Besylate | 17 | $95 | $6 |
| Clonazepam | 13 | $77 | $6 |
| Naproxen | 11 | $67 | $6 |
Money from drug and device companies
$30 in 2021
A payment is not proof that care is biased.
| Medtronic | Pi | $30 | 1 payment
|
See the published payment
| Medtronic | Meals · 2021-03-13 | Pi | $30 |
Professional record
- NPI
- 1154742831
- Licence
- CA 20A6615
- Trained
- University of North Texas Hsc, College of Osteopathic Med, 1993
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2670 S White Rd Ste 160, San Jose, CA, 95148
- NPI first listed
- 2013-12-23
- NPI last updated
- 2025-06-09
- NPI record certified
- 2025-06-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1333 Meridian Ave, San Jose, CA, 95125 · 1642 E Capitol Expy, San Jose, CA, 95121 · 455 Oconnor Dr, San Jose, CA, 95128